[HTML][HTML] Remdesivir: a review in COVID-19
HA Blair - Drugs, 2023 - Springer
Remdesivir (Veklury®), a nucleotide analogue prodrug with broad-spectrum antiviral activity,
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients
M Sun, H Lai, J Huang, J Liu, Y Li, J Tian… - Journal of …, 2023 - academic.oup.com
Background Molnupiravir has been considered a promising candidate for COVID-19. Its
efficacy and safety in non-severe COVID-19 patients and the differences between patients …
efficacy and safety in non-severe COVID-19 patients and the differences between patients …
[HTML][HTML] The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one
MT Kelleni - Inflammopharmacology, 2023 - Springer
Abstract For over 3.5 years, SARS CoV-2 is continuing to evolve threatening to return all and
any improvement the world has made into square one. In this clinically oriented systematic …
any improvement the world has made into square one. In this clinically oriented systematic …
Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (Version 2)
Background: Clinicians and patients want to know the benefits and harms of outpatient
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
Ongoing need for clinical trials and contemporary end points for outpatient COVID-19
TC Lee, DR Boulware - Annals of internal medicine, 2023 - acpjournals.org
The ACP presents recommendations for outpatient treatment of COVID-19 based on
Sommer and colleagues' systematic review. The editorialists commend the authors of the …
Sommer and colleagues' systematic review. The editorialists commend the authors of the …
Outpatient treatment of confirmed COVID-19: living, rapid practice points from the American College of Physicians (version 2)
A Qaseem, J Yost, GM Abraham… - Annals of Internal …, 2023 - acpjournals.org
Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19
continues to evolve with new data. This is version 2 of the American College of Physicians …
continues to evolve with new data. This is version 2 of the American College of Physicians …
[HTML][HTML] COVID-19: Management of adults with acute illness in the outpatient setting
INTRODUCTION—At the end of 2019, a novel coronavirus rapidly spread throughout the
world, resulting in a global pandemic. The virus was designated severe acute respiratory …
world, resulting in a global pandemic. The virus was designated severe acute respiratory …
[HTML][HTML] Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations
Q Wang, Y Cao, X Liu, Y Fu, J Zhang… - PLOS Neglected …, 2024 - journals.plos.org
Background Tuberculosis (TB) and COVID-19 co-infection poses a significant global health
challenge with increased fatality rates and adverse outcomes. However, the existing …
challenge with increased fatality rates and adverse outcomes. However, the existing …
SARS-CoV-2 Encephalitis versus Influenza Encephalitis: More Similarities than Differences
KLE Hon, AKC Leung, YW Tan… - Current Pediatric …, 2024 - ingentaconnect.com
Background: From time to time, physicians face challenging diagnostic and therapeutic
issues concerning the acute management of children with viral encephalitis. Objectives: The …
issues concerning the acute management of children with viral encephalitis. Objectives: The …
[HTML][HTML] The Influence of Comorbidities, General Health Status, and Self-Care Self-Efficacy on COVID-19 Symptoms During the Omicron Wave
MM Jose, J Feng, HT Nguyen, C Juneau, BM Manakatt… - Cureus, 2023 - ncbi.nlm.nih.gov
Background The emergence of the less virulent COVID-19 strains such as Omicron and its
subvariants shifted the paradigm of COVID-19 treatment from inpatient treatment to regular …
subvariants shifted the paradigm of COVID-19 treatment from inpatient treatment to regular …